These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10716970)

  • 1. Re: Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Gavelli A; Brossette N; Baqué P; Benchimol D; Bourgeon A; Staccini P; Rossi B
    J Natl Cancer Inst; 2000 Mar; 92(6):494-5. PubMed ID: 10716970
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous or intrahepatic injection of suicide gene modified tumour cells induces a systemic antitumour response in a metastatic model of colon carcinoma in rats.
    Pierrefite-Carle V; Baqué P; Gavelli A; Brossette N; Benchimol D; Bourgeon A; Saint Paul MC; Staccini P; Rossi B
    Gut; 2002 Mar; 50(3):387-91. PubMed ID: 11839720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
    Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
    Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination by suicide gene therapy against a model of hepatic metastasis from colon cancer in the rat].
    Gavelli A; Baqué P; Mala M; Saint-Paul MC; Staccini P; Brossette N; Chazal M; Milano G; Gugenheim J; Benchimol D; Bourgeon A; Huguet C; Rossi B; Pierrefite-Carle V
    Ann Chir; 2000 Jul; 125(6):552-9. PubMed ID: 10986767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.
    Crystal RG; Hirschowitz E; Lieberman M; Daly J; Kazam E; Henschke C; Yankelevitz D; Kemeny N; Silverstein R; Ohwada A; Russi T; Mastrangeli A; Sanders A; Cooke J; Harvey BG
    Hum Gene Ther; 1997 May; 8(8):985-1001. PubMed ID: 9195221
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of experimental liver tumor after distant intra-hepatic injection of cytosine deaminase-expressing tumor cells and 5-fluorocytosine treatment.
    Pierrefite-Carle V; Baque P; Gavelli A; Benchimol D; Bourgeon A; Milano G; Saint-Paul MC; Rossi B
    Int J Mol Med; 2000 Mar; 5(3):275-8. PubMed ID: 10677568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.
    Humphreys MJ; Ghaneh P; Greenhalf W; Campbell F; Clayton TM; Everett P; Huber BE; Richards CA; Ford MJ; Neoptolemos JP
    Gene Ther; 2001 Aug; 8(16):1241-7. PubMed ID: 11509957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
    Bentires-Alj M; Hellin AC; Lechanteur C; Princen F; Lopez M; Fillet G; Gielen J; Merville MP; Bours V
    Cancer Gene Ther; 2000 Jan; 7(1):20-6. PubMed ID: 10678352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
    Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
    Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors.
    Nakamura T; Sasaki T; Fujimori M; Yazawa K; Kano Y; Amano J; Taniguchi S
    Biosci Biotechnol Biochem; 2002 Nov; 66(11):2362-6. PubMed ID: 12506973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme/prodrug-based tumor vaccination: all politics (and immunity) are local.
    Morris JC
    J Natl Cancer Inst; 1999 Dec; 91(23):1986-9. PubMed ID: 10580014
    [No Abstract]   [Full Text] [Related]  

  • 16. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
    Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
    Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.